skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
London – November 29, 2018 – Scrip Intelligence, part of the Informa Pharma Intelligence family, today announces the winners of its 14th Annual Scrip Awards; Novartis was the night’s biggest winner, taking home two wins for Syneos Health’s Best New Drug Award for Kymriah and Executive of the Year – For Large & Medium Cap Companies (sponsored by Lachman Consultants) for Vas Narasimham. MSD took home the coveted Pharma Company of the Year Award (sponsored by CMIC) and shared the win with AstraZeneca for Licensing Deal of the Year (sponsored by Worldwide Clinical Trials) for their deal for covering Lynparza and selumetinib. The 2018 Scrip’s Lifetime Achievement Award (sponsored by ICON) winner was Sir John Bell.

The Scrip Awards acknowledge and commend the pharmaceutical sector’s stand-out performers across all areas of the industry, recognizing both corporate and individual achievements. New this year, Scrip introduced the Best Use of Real-World Evidence category to witness the increasing importance of proving the benefits of new drugs in the market.

 

Category

Winner

Scrip’s Lifetime Achievement Award (sponsored by ICON)

Sir John Bell

Pharma Company of the Year (sponsored by CMIC)

MSD

Syneos Health's Best New Drug Award (sponsored by Syneos Health)

Novartis’s Kymriah and Kite Pharma/Gilead Sciences’ Yescarta

WuXi AppTec’s Biotech Company of the Year Award (sponsored by WuXI AppTec)

AveXis

Community Partnership of the Year (sponsored by Medidata)

Beximco Pharma with DSM Nutritional Products and Sight & Life Global Nutrition Research Institute

IQVIA’s Clinical Advance of the Year Award (sponsored by IQVIA)

GW Pharmaceuticals’ Phase III GWPCARE4 trial of Epidiolex for refractory epilepsy

Executive of the Year – For Large & Medium Cap Companies (sponsored by Lachman Consultants)

Vas Narasimhan, CEO of Novartis

Executive of the Year – For Small Cap & Private Pharma Companies (sponsored by Lachman Consultants)

Raman Singh, CEO of Mundipharma Singapore

Licensing Deal of the Year (sponsored by Worldwide Clinical Trials)

AstraZeneca and Merck & Co (MSD) for Lynparza and selumetinib

Masters Speciality Pharma’s Best Company in an Emerging Market (sponsored by Masters Speciality Pharma)

WuXi Biologics

Business Development Team of the Year (sponsored by Skipta)

Evotec’s business development team

Best Contract Research Organization – Full-Service Providers

IQVIA

Best Contract Research Organization – Specialist Providers

Cytel

Best Partnership Alliance

F-star and Denali Therapeutics to develop a multi-specific platform for delivery of medicines across the blood-brain barrier

Financing Deal of the Year – Public (sponsored by MC Services)

Ablynx’s $200m US IPO on NASDAQ

Financing Deal of the Year – Private (sponsored by MC Services)

BioNTech’s $270m Series A financing

Best Use of Real-World Evidence

PAREXEL International’s Multiple Sclerosis Algorithms Development and Validation project

Best Technological Development in Clinical Trials – Clinical Sponsor-focused

Covance’s Xcellerate CRA Dashboard

Best Technological Development in Clinical Trials – Tech Sponsor-focused

Medidata’s Medidata Rave Engage

To see the full list of Scrip Awards winners please visit: www.scripawards.com.


Mike Ward, Global Head of Content, said: "Year after year it has become increasingly important for us to take a step back and recognize the exceptional accomplishments of both companies and individuals driving the pharmaceutical industry forward. Tasked with the challenge of improving global health, R&D innovation this past year has driven more activity in the sector than ever before. The quality of the entries this year was outstanding and we’re looking forward to seeing this momentum continue in the year to come.”

The Scrip Awards are managed by Scrip Intelligence, the premier source of information for the pharmaceutical industry and part of Informa Pharma Intelligence. Scrip provides information, analysis and knowledge for business decision makers in a changing and increasingly complex pharmaceuticals environment. The awards were announced during a ceremony presented by the Right Honourable Lord (William) Hague on November 28, 2018.

About Informa Pharma Intelligence

Informa Pharma Intelligence powers a full suite of analysis products - Datamonitor Healthcare, Sitetrove, Trialtrove, Pharmaprojects, Medtrack, Biomedtracker, Scrip, Pink Sheet and In Vivo – to deliver the data needed by the pharmaceutical and biomedical industry to make decisions and create real-world opportunities for growth.

With more than 500 analysts keeping their fingers on the pulse of the industry, no key disease, clinical trial, drug approval or R&D project isn’t covered through the breadth and depth of data available to customers. For more information visit pharmaintelligence.informa.com.

Media Contact    
Informa Pharma Intelligence
Rachel Wyncoop
informapharma@diffusionpr.com
646.571.0120

Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: